Skip to main content
Signal8
Launch Terminal
Santos David A profile photo

David A. Santos

CIK: 0001820066

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (15.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (53.8%)

Compensation grants

Other (G, F, J, C, D, …)4 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RIGEL PHARMACEUTICALS INC logo
RIGL

RIGEL PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Sep 1, 2026
    Tax Payment(F)
    Direct
    874 shares at avg. $47.50$42K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Jun 17, 2026
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    7.4K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Jun 1, 2026
    Tax Payment(F)
    Direct
    874 shares at avg. $29.86$26K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 17, 2026
    Award(A)
    Direct
    19.4K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 10, 2026
    Tax Payment(F)
    Direct
    3.5K shares at avg. $34.62$123K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 2, 2026
    Tax Payment(F)
    Direct
    5.7K shares at avg. $36.01$206K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Sep 15, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    7.4K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Mar 17, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    6.9K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Mar 17, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    7.9K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 5, 2025
    Sale(S)
    Direct
    1.8K shares at avg. $21.93$39K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 4, 2025
    Sale(S)
    Direct
    2.1K shares at avg. $20.92$44K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Jan 29, 2025
    Award(A)
    Direct
    19.7K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Nov 25, 2024
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    8K shares-

1-13 of 13

About Santos David A

Santos David A (SEC CIK 0001820066) files insider reports with the SEC as EVP, Chief Commercial Officer of RIGEL PHARMACEUTICALS INC (RIGL).

Signal8 holds 11 ownership filings by Santos David A, all Form 4s, filed between Nov 26, 2024 and Sep 3, 2026. Those filings report 13 transactions, from Nov 25, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Santos David A's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Santos David A

  • Sep 1, 2026: Tax withholding of RIGL shares (Form 4, code F).
  • Jun 17, 2026: Grant or award of RIGL derivative securities (Form 4, code A).
  • Jun 1, 2026: Tax withholding of RIGL shares (Form 4, code F).
  • Feb 17, 2026: Grant or award of RIGL shares (Form 4, code A).
  • Feb 10, 2026: Tax withholding of RIGL shares (Form 4, code F).

Other insiders filing for RIGEL PHARMACEUTICALS INC (RIGL)

How to read Form 4 transaction codes